United Therapeutics (UTHR) Change in Cash (2016 - 2025)
Historic Change in Cash for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to -$253.0 million.
- United Therapeutics' Change in Cash fell 22764.88% to -$253.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$213.8 million, marking a year-over-year decrease of 14791.57%. This contributed to the annual value of $489.5 million for FY2024, which is 9858.01% up from last year.
- United Therapeutics' Change in Cash amounted to -$253.0 million in Q3 2025, which was down 22764.88% from -$306.8 million recorded in Q2 2025.
- In the past 5 years, United Therapeutics' Change in Cash registered a high of $202.7 million during Q1 2025, and its lowest value of -$306.8 million during Q2 2025.
- In the last 5 years, United Therapeutics' Change in Cash had a median value of $43.8 million in 2024 and averaged $31.7 million.
- Over the last 5 years, United Therapeutics' Change in Cash had its largest YoY gain of 188571.43% in 2023, and its largest YoY loss of 43149.17% in 2023.
- Over the past 5 years, United Therapeutics' Change in Cash (Quarter) stood at -$13.7 million in 2021, then surged by 59.12% to -$5.6 million in 2022, then soared by 1885.71% to $100.0 million in 2023, then soared by 43.3% to $143.3 million in 2024, then plummeted by 276.55% to -$253.0 million in 2025.
- Its Change in Cash stands at -$253.0 million for Q3 2025, versus -$306.8 million for Q2 2025 and $202.7 million for Q1 2025.